美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
68462-370-05	68462-370	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	150 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-05)
68462-370-30	68462-370	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	150 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-30)
68462-370-90	68462-370	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	150 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-370-90)
68462-371-05	68462-371	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	200 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-05)
68462-371-30	68462-371	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	200 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-30)
68462-371-90	68462-371	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	200 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-90)
68462-372-05	68462-372	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	25 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-372-05)
68462-372-30	68462-372	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	25 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-372-30)
68462-372-90	68462-372	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	25 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-372-90)
68462-373-05	68462-373	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	50 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-05)
68462-373-30	68462-373	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	50 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-30)
68462-373-90	68462-373	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	50 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-90)
68462-374-05	68462-374	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	100 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-05)
68462-374-30	68462-374	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	100 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-30)
68462-374-90	68462-374	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201	N/A	ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	100 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-90)
72603-120-01	72603-120	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101	N/A	ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	25 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-120-01)
72603-121-01	72603-121	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101	N/A	ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	50 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-121-01)
72603-122-01	72603-122	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101	N/A	ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	100 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-122-01)
72603-123-01	72603-123	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101	N/A	ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	150 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-123-01)
72603-124-01	72603-124	HUMAN PRESCRIPTION DRUG	TOPIRAMATE	topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101	N/A	ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	200 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-124-01)